Skip to content
10-K/A

Annual Report

Vaccinex, Inc. VCNX

0000950170-24-048163

← back to feed
Filed
Apr 25, 2024 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 22, 2024 1.23M sh
Shares Diluted FY 2023 · Dec 31, 2023 463.65K sh
Shares Diluted restated FY 2023 · Dec 31, 2022 202.08K sh
Capex FY 2023 · Dec 31, 2023 $67K
Capex FY 2023 · Dec 31, 2022 $99K
Operating Cash Flow restated FY 2023 · Dec 31, 2023 −$17.23M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$19.07M
Long Term Debt FY 2023 · Dec 31, 2023 $26K
Long Term Debt FY 2023 · Dec 31, 2022 $101K
Short Term Debt FY 2023 · Dec 31, 2023 $75K
Short Term Debt FY 2023 · Dec 31, 2022 $74K
Cash And Equivalents FY 2023 · Dec 31, 2023 $1.54M
Cash And Equivalents FY 2023 · Dec 31, 2022 $6.39M
Current Liabilities FY 2023 · Dec 31, 2023 $5.92M
Current Liabilities FY 2023 · Dec 31, 2022 $2.54M
Total Liabilities FY 2023 · Dec 31, 2023 $5.94M
Total Liabilities FY 2023 · Dec 31, 2022 $2.78M
Current Assets FY 2023 · Dec 31, 2023 $3.35M
Current Assets FY 2023 · Dec 31, 2022 $7.48M
Total Assets FY 2023 · Dec 31, 2023 $3.63M
Total Assets FY 2023 · Dec 31, 2022 $7.98M
Eps Diluted FY 2023 · Dec 31, 2023 −$43.68
Eps Diluted restated FY 2023 · Dec 31, 2022 −$98.05
Eps Basic FY 2023 · Dec 31, 2023 −$43.68
Eps Basic restated FY 2023 · Dec 31, 2022 −$98.05
Sga Expense FY 2023 · Dec 31, 2023 $6.88M
Sga Expense FY 2023 · Dec 31, 2022 $6.2M
Rd Expense FY 2023 · Dec 31, 2023 $16.57M
Rd Expense FY 2023 · Dec 31, 2022 $13.98M
Net Income FY 2023 · Dec 31, 2023 −$20.25M
Net Income FY 2023 · Dec 31, 2022 −$19.82M
Operating Income FY 2023 · Dec 31, 2023 −$22.89M
Operating Income FY 2023 · Dec 31, 2022 −$19.91M
Revenue FY 2023 · Dec 31, 2023 $570K
Revenue FY 2023 · Dec 31, 2022 $275K